Title : FE65 defines the efficacy of tamoxifen treatment via osteopontin expression in estrogen receptor-positive breast cancer.

Pub. Date : 2022 Jun

PMID : 35447603






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 FE65 defines the efficacy of tamoxifen treatment via osteopontin expression in estrogen receptor-positive breast cancer. Tamoxifen estrogen receptor 1 Homo sapiens
2 Therefore, mechanistic exploration of tamoxifen (TAM) resistance is considered pivotal to improve the prognosis of ER positive breast cancer patients. Tamoxifen estrogen receptor 1 Homo sapiens
3 Therefore, mechanistic exploration of tamoxifen (TAM) resistance is considered pivotal to improve the prognosis of ER positive breast cancer patients. Tamoxifen estrogen receptor 1 Homo sapiens
4 In addition, results suggested the clinical value of FE65 as potential prognostic factor and surrogate marker of TAM therapy in ER-positive breast cancer patients. Tamoxifen estrogen receptor 1 Homo sapiens